Multi-center, open-label, multiple dose study in mild to moderate asthmatics (with IgE/body weight combinations above that in the SmPC dosing table) to determine safety, tolerability, pharmacokinetics, and pharmacodynamics of omalizumab
Laufzeit: 01.01.2007 - 31.12.2009
imported
Kurzfassung
Dosiserweiterungsstudie von Omalizumab bei Patienten mit mildem bis moderatem Asthma
Veröffentlichungen
- Chipps, B; Buhl, R; Beeh, KM et al.
- Improvement in quality of life with omalizumab in patients with severe allergic asthma.
